David L. Evers

1.1k total citations
28 papers, 766 citations indexed

About

David L. Evers is a scholar working on Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David L. Evers has authored 28 papers receiving a total of 766 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Epidemiology and 3 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David L. Evers's work include Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (6 papers) and Molecular Biology Techniques and Applications (4 papers). David L. Evers is often cited by papers focused on Cytomegalovirus and herpesvirus research (9 papers), Herpesvirus Infections and Treatments (6 papers) and Molecular Biology Techniques and Applications (4 papers). David L. Evers collaborates with scholars based in United States, Australia and China. David L. Evers's co-authors include Jeffrey T. Mason, Timothy J. O’Leary, Eng‐Shang Huang, Carol B. Fowler, Shu‐Mei Huong, Xin Wang, Zhigang Zhang, Kevin G. Rice, Brady R. Cunningham and John C. Drach and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Journal of Virology.

In The Last Decade

David L. Evers

28 papers receiving 741 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David L. Evers United States 17 350 221 95 91 75 28 766
Nevena Veljković Serbia 18 405 1.2× 197 0.9× 61 0.6× 100 1.1× 53 0.7× 58 801
Joachim Seipelt Austria 17 308 0.9× 181 0.8× 78 0.8× 228 2.5× 47 0.6× 22 972
Xue-Fei Cai China 16 438 1.3× 356 1.6× 87 0.9× 68 0.7× 22 0.3× 41 882
Hans Timmermans Netherlands 13 400 1.1× 204 0.9× 39 0.4× 141 1.5× 44 0.6× 16 840
Simon A. Cobbold Australia 21 514 1.5× 279 1.3× 157 1.7× 116 1.3× 41 0.5× 34 1.4k
Zhiguang Ren China 16 272 0.8× 152 0.7× 109 1.1× 53 0.6× 83 1.1× 33 604
Yiliang Wang China 16 338 1.0× 113 0.5× 89 0.9× 127 1.4× 26 0.3× 25 703
Sajib Chakraborty Bangladesh 16 525 1.5× 92 0.4× 98 1.0× 90 1.0× 29 0.4× 60 992
Anderson Assunção Andrade Brazil 16 217 0.6× 240 1.1× 114 1.2× 115 1.3× 168 2.2× 30 900
Wenzhe Li China 21 666 1.9× 184 0.8× 106 1.1× 405 4.5× 98 1.3× 65 1.2k

Countries citing papers authored by David L. Evers

Since Specialization
Citations

This map shows the geographic impact of David L. Evers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Evers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Evers more than expected).

Fields of papers citing papers by David L. Evers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Evers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Evers. The network helps show where David L. Evers may publish in the future.

Co-authorship network of co-authors of David L. Evers

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Evers. A scholar is included among the top collaborators of David L. Evers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Evers. David L. Evers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McAnulty, Michael J., et al.. (2021). Pre-clinical drug-drug interaction (DDI) of gefitinib or erlotinib with Cytochrome P450 (CYP) inhibiting drugs, fluoxetine and/or losartan. Current Research in Toxicology. 2. 217–224. 11 indexed citations
2.
Evers, David L., et al.. (2017). A simple empirical algorithm to distinguish among Leishmania braziliensis, major, and tropica species by MALDI-TOF mass spectrometry. Journal of Microbiological Methods. 148. 46–48. 1 indexed citations
3.
Lin, Yanli, Qixin Leng, Zhengran Jiang, et al.. (2017). A classifier integrating plasma biomarkers and radiological characteristics for distinguishing malignant from benign pulmonary nodules. International Journal of Cancer. 141(6). 1240–1248. 33 indexed citations
4.
Evers, David L., et al.. (2014). Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects. Science and Engineering Ethics. 21(4). 1049–1064. 17 indexed citations
5.
Evers, David L., et al.. (2013). Laboratory Decontamination of HHS-Listed and HHS/USDA Overlap Select Agents and Toxins. Applied Biosafety. 18(2). 59–72. 2 indexed citations
6.
He, Junkun, David L. Evers, Timothy J. O’Leary, & Jeffrey T. Mason. (2012). Immunoliposome-PCR: a generic ultrasensitive quantitative antigen detection system. Journal of Nanobiotechnology. 10(1). 26–26. 20 indexed citations
7.
Evers, David L., Junkun He, Yeon Ho Kim, Jeffrey T. Mason, & Timothy J. O’Leary. (2011). Paraffin Embedding Contributes to RNA Aggregation, Reduced RNA Yield, and Low RNA Quality. Journal of Molecular Diagnostics. 13(6). 687–694. 41 indexed citations
8.
Evers, David L., Carol B. Fowler, Brady R. Cunningham, Jeffrey T. Mason, & Timothy J. O’Leary. (2011). The Effect of Formaldehyde Fixation on RNA. Journal of Molecular Diagnostics. 13(3). 282–288. 95 indexed citations
9.
Evers, David L., et al.. (2011). Regulatory and Ethical Issues on the Utilization of FFPE Tissues in Research. Methods in molecular biology. 724. 1–21. 3 indexed citations
10.
Evers, David L., Carol B. Fowler, Robert E. Cunningham, Jeffrey T. Mason, & Timothy J. O’Leary. (2007). A novel HPLC method reveals that precipitation of 2′-deoxyadenosine 5′-monophosphate with lithium perchlorate/acetone leads to base depurination. Analytical Biochemistry. 370(2). 255–257. 1 indexed citations
11.
Zhang, Zhigang, David L. Evers, Joseph McCarville, et al.. (2006). Evidence that the Human Cytomegalovirus IE2-86 Protein Binds mdm2 and Facilitates mdm2 Degradation. Journal of Virology. 80(8). 3833–3843. 26 indexed citations
12.
Evers, David L., et al.. (2005). Human cytomegalovirus-inhibitory flavonoids: Studies on antiviral activity and mechanism of action. Antiviral Research. 68(3). 124–134. 117 indexed citations
13.
Evers, David L., Xin Wang, Shu‐Mei Huong, Kenneth A. Andreoni, & Eng‐Shang Huang. (2004). Inhibition of human cytomegalovirus signaling and replication by the immunosuppressant FK778. Antiviral Research. 65(1). 1–12. 37 indexed citations
14.
Evers, David L., et al.. (2004). 3,4′,5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling. Antiviral Research. 63(2). 85–95. 54 indexed citations
15.
Evers, David L., Julie M. Breitenbach, Katherine Z. Borysko, Leroy B. Townsend, & John C. Drach. (2002). Inhibition of Cyclin-Dependent Kinase 1 by Purines and Pyrrolo[2,3-d]Pyrimidines Does Not Correlate with Antiviral Activity. Antimicrobial Agents and Chemotherapy. 46(8). 2470–2476. 16 indexed citations
16.
Evers, David L., et al.. (2002). Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus. Antiviral Research. 56(1). 61–72. 47 indexed citations
17.
Collard, Wendy T., David L. Evers, Donald L. McKenzie, & Kevin G. Rice. (1999). Synthesis of homogeneous glycopeptides and their utility as DNA condensing agents. Carbohydrate Research. 323(1-4). 176–184. 11 indexed citations
18.
Mo, Hanqing, Kevin G. Rice, David L. Evers, et al.. (1999). Xanthosoma sagittifolium Tubers Contain a Lectin with Two Different Types of Carbohydrate-binding Sites. Journal of Biological Chemistry. 274(47). 33300–33305. 19 indexed citations
19.
Kwok, Kai Y., Donald L. McKenzie, David L. Evers, & Kevin G. Rice. (1999). Formulation of highly soluble poly(ethylene glycol)‐peptide DNA condensates. Journal of Pharmaceutical Sciences. 88(10). 996–1003. 48 indexed citations
20.
Evers, David L., et al.. (1998). Preparative Purification of a High-Mannose TypeN-Glycan from Soy Bean Agglutinin by Hydrazinolysis and Tyrosinamide Derivatization. Analytical Biochemistry. 265(2). 313–316. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nevena Veljković Breakdown of academic impact, for papers by Joachim Seipelt Breakdown of academic impact, for papers by Xue-Fei Cai Breakdown of academic impact, for papers by Hans Timmermans Breakdown of academic impact, for papers by Simon A. Cobbold Breakdown of academic impact, for papers by Zhiguang Ren Breakdown of academic impact, for papers by Yiliang Wang Breakdown of academic impact, for papers by Sajib Chakraborty Breakdown of academic impact, for papers by Anderson Assunção Andrade Breakdown of academic impact, for papers by Wenzhe Li
Rankless by CCL
2026